Dogwood Therapeutics, Inc.
DWTX
$1.70
$0.010.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.03% | -4.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -75.92% | 302.97% | |||
| Operating Income | 75.92% | -302.97% | |||
| Income Before Tax | 76.19% | -313.59% | |||
| Income Tax Expenses | 2,371.43% | -1,500.00% | |||
| Earnings from Continuing Operations | 75.99% | -313.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 75.99% | -313.53% | |||
| EBIT | 75.92% | -302.97% | |||
| EBITDA | 75.92% | -304.73% | |||
| EPS Basic | 96.83% | -311.74% | |||
| Normalized Basic EPS | 96.86% | -311.79% | |||
| EPS Diluted | 96.83% | -311.74% | |||
| Normalized Diluted EPS | 96.86% | -311.79% | |||
| Average Basic Shares Outstanding | 656.55% | 0.43% | |||
| Average Diluted Shares Outstanding | 656.55% | 0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||